// STATE LEGISLATION TRACKER

Kansas HB 2029 — Reconciling multiple amendments to certain statutes.

⚖️ NEUTRAL for peptide users 👤 NONE user impact 📜 Status: Passed chamber

State: Kansas
Bill: HB 2029
Filed: 2025-01-17
Read the bill: OpenStates →
Last reviewed: 2026-06-21

Plain-English Summary

Kansas HB2029 does not appear to target peptides, prescribing, compounding, telehealth, clinician scope, controlled substances, or prescription monitoring. The official Kansas bill page describes it as a transportation memorial-highway bill, so it has no direct peptide-ecosystem impact.

Key Points

No identified change to compounded peptide access
No identified change to off-label prescribing
No identified change to telehealth prescribing
No identified change to NP or naturopath scope
No identified change to PDMP or controlled substances

What to Watch For

Note The bill appears unrelated to healthcare; monitor only if later amendments add medical or pharmacy language.

Note OpenStates had a refetch issue, so status should be checked against the Kansas Legislature page before publication.

Where the Bill Stands

The Kansas Legislature page shows HB2029 passed the House as amended on February 7, 2025.

— Ed. Our analysis pulls public bill metadata from OpenStates and is enriched with research-model context. We don't quote bill text we haven't read directly. If this bill matters to your practice or treatment access, read the official source linked above before taking action. We're an educational research directory, not a legal or medical reference.

Bill page generated 2026-06-21 · enriched via codex gpt-5.5
Source: OpenStates v3 API · View official bill · ← back to all laws